These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 2123104

  • 1. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M, Jain S, Baquer NZ.
    Biochem Pharmacol; 1990 Nov 15; 40(10):2215-8. PubMed ID: 2123104
    [Abstract] [Full Text] [Related]

  • 2. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS, Klimova GI, Nersisian AA.
    Biokhimiia; 1981 Nov 15; 46(11):2043-55. PubMed ID: 6797482
    [Abstract] [Full Text] [Related]

  • 3. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS.
    Biokhimiia; 1983 Sep 15; 48(9):1513-21. PubMed ID: 6414536
    [Abstract] [Full Text] [Related]

  • 4. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 15; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 5. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C, Mayanil K, Baquer NZ.
    Biochem Pharmacol; 1982 Dec 01; 31(23):3925-7. PubMed ID: 6818972
    [Abstract] [Full Text] [Related]

  • 6. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ, Oreland L, Callingham BA.
    J Pharm Pharmacol; 1981 Jun 01; 33(6):341-7. PubMed ID: 6115003
    [No Abstract] [Full Text] [Related]

  • 7. Modulation by phospholipids of the activity of monoamine oxidase purified from pig liver.
    Inagaki T, Rao NA, Yagi K.
    J Biochem; 1986 Sep 01; 100(3):597-603. PubMed ID: 3096981
    [Abstract] [Full Text] [Related]

  • 8. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV, Heikkila RE.
    Life Sci; 1986 Apr 21; 38(16):1459-62. PubMed ID: 3084895
    [Abstract] [Full Text] [Related]

  • 9. Identification of type A monoamine oxidase in mouse and rabbit liver mitochondria.
    Suzuki O, Mizutani S, Katsumata Y, Oya M.
    Experientia; 1981 Jan 15; 37(1):18-9. PubMed ID: 6781927
    [Abstract] [Full Text] [Related]

  • 10. Properties of monoamine oxidase in monkey heart.
    Katayama M, Kobayashi S, Oguchi K, Yasuhara H.
    Jpn J Pharmacol; 1984 Aug 15; 35(4):425-31. PubMed ID: 6438377
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR, Palfreyman MG, Robin M, Zreika M.
    Br J Pharmacol; 1986 Jan 15; 87(1):257-64. PubMed ID: 3082400
    [Abstract] [Full Text] [Related]

  • 12. The functional consequences of inhibition of monoamine oxidase type B: comparison of the pharmacological properties of L-deprenyl and MDL 72145.
    Fozard JR, Zreika M, Robin M, Palfreyman MG.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 15; 331(2-3):186-93. PubMed ID: 3937059
    [Abstract] [Full Text] [Related]

  • 13. Biochemical characterization of the active site of brain monoamine oxidase.
    Youdim MB.
    Monogr Neural Sci; 1980 Nov 15; 7():176-92. PubMed ID: 6785574
    [Abstract] [Full Text] [Related]

  • 14. Substrate selectivity of type A and type B monoamine oxidase in rat brain.
    Kinemuchi H, Wakui Y, Kamijo K.
    J Neurochem; 1980 Jul 15; 35(1):109-15. PubMed ID: 6778959
    [No Abstract] [Full Text] [Related]

  • 15. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ, Mantle TJ, Tipton KF.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3555-61. PubMed ID: 6817759
    [Abstract] [Full Text] [Related]

  • 16. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM, Masini-Repiso AM, Costamagna ME, Pellizas C, Coleoni AH.
    J Endocrinol; 1994 Nov 15; 143(2):303-8. PubMed ID: 7829993
    [Abstract] [Full Text] [Related]

  • 17. Purification and properties of mitochondrial monoamine oxidase type A from human placenta.
    Weyler W, Salach JI.
    J Biol Chem; 1985 Oct 25; 260(24):13199-207. PubMed ID: 3932340
    [Abstract] [Full Text] [Related]

  • 18. Substrate specificity and inhibitor sensitivity of monoamine oxidase in rat kidney mitochondria.
    Lyles GA, Shaffer CJ.
    Biochem Pharmacol; 1979 Apr 01; 28(7):1099-106. PubMed ID: 444267
    [No Abstract] [Full Text] [Related]

  • 19. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
    Schoepp DD, Azzaro AJ.
    J Neurochem; 1981 Aug 01; 37(2):527-30. PubMed ID: 6790675
    [Abstract] [Full Text] [Related]

  • 20. The reaction of bovine and rat liver monoamine oxidase with [14C]-clorgyline and [14C]-deprenyl.
    Salach JI, Detmer K, Youdim MB.
    Mol Pharmacol; 1979 Jul 01; 16(1):234-41. PubMed ID: 481419
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.